Crinetics Pharmaceuticals, Inc. logo CRNX - Crinetics Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 18
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $85.83 DETAILS
HIGH: $105.00
LOW: $67.00
MEDIAN: $85.50
CONSENSUS: $85.83
UPSIDE: 133.23%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1
Revenue
Revenue 10.7 6.2 0.1 1.0 0.4 0 0 0.4 0.6 0 0.3 1.0 2.7 0.7 0.5 0.4 3.1 1.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 10.5 6.2 0.1 1.0 0.4 0 0 0.4 0.6 0 0.3 1.0 2.7 0.7 0.5 0.4 3.1 1.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses
R&D Expenses 100.1 85.1 90.5 80.3 76.2 66.6 61.9 58.3 53.3 45.6 43.8 40.6 38.5 37.0 32.0 33.0 28.3 24.6 21.6 20.5 17.6 16.8 13.7 12.6 13.9 12.1 11.8 10.3 7.3 7.7 6.9 5.2 4.7 2.6 2.5 2.1 2.1
SG&A Expenses 50.8 53.7 52.3 49.8 35.5 28.2 25.9 24.8 20.8 17.1 15.5 13.3 12.2 11.3 11.9 10.5 8.7 7.4 6.2 5.6 5.3 5.0 4.8 4.3 4.0 3.4 3.9 3.1 3.2 2.6 1.7 1.1 1.2 0.5 0.5 0.4 0.6
Other Expenses 0 1.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.1) (0.3) (0.5) 0 (0.4) (0.8) (0.5) (0.7) (0.4) (0.5) (0.6) (0.8) (0.0)
Operating Expenses 150.9 139.8 142.7 130.1 111.8 94.7 87.8 83.2 74.2 62.7 59.3 54.0 50.7 48.3 43.9 43.5 37.0 32.0 27.8 26.1 22.9 21.8 18.5 16.9 17.8 15.2 15.2 13.3 10.0 9.4 8.1 5.7 5.5 2.5 2.4 1.6 2.6
Operating Income
Operating Income (140.4) (133.7) (142.6) (129.1) (111.4) (94.7) (87.8) (82.8) (73.5) (62.7) (59.0) (53.0) (48.0) (47.6) (43.5) (43.0) (33.8) (30.9) (27.8) (26.1) (22.9) (21.8) (18.5) (16.9) (17.8) (15.2) (15.2) (13.3) (10.0) (9.4) (8.1) (5.7) (5.5) (2.5) (2.4) (1.6) (2.6)
Interest Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0.0 0.0
Interest Income 12.7 11.2 12.5 13.5 14.8 14.4 11.0 8.7 7.3 6.7 2.6 2.1 2.0 1.9 1.5 0.7 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.6 0.7 0.8 1.0 1.0 1.0 0.5 0.2 0.1 0.0 0.0 0.0 0.0
Profitability
EBITDA (139.2) (132.7) (141.6) (128.2) (110.5) (94.0) (87.0) (82.0) (73.1) (62.4) (58.7) (52.7) (47.7) (47.3) (43.2) (42.8) (33.6) (30.7) (27.6) (25.9) (22.7) (21.6) (18.2) (16.7) (17.5) (15.0) (15.0) (13.1) (9.8) (8.3) (7.9) (5.6) (5.5) (2.5) (2.4) (1.6) (2.6)
EBIT (140.4) (133.7) (142.6) (129.1) (111.4) (94.7) (87.8) (82.8) (73.5) (62.7) (59.0) (53.0) (48.0) (47.6) (43.5) (43.0) (33.8) (30.9) (27.8) (26.1) (22.9) (21.8) (18.5) (16.9) (17.8) (15.2) (15.2) (13.3) (10.0) (8.5) (8.1) (5.7) (5.5) (2.5) (2.4) (1.6) (2.6)
Income Before Tax (127.8) (122.6) (130.1) (115.6) (96.8) (80.6) (76.8) (74.1) (66.9) (60.1) (57.5) (51.0) (46.0) (45.0) (41.9) (42.4) (34.6) (30.8) (27.9) (26.1) (22.9) (21.6) (18.3) (16.5) (17.4) (14.5) (14.4) (12.4) (9.0) (8.5) (7.6) (5.6) (5.5) (2.5) (2.4) (1.6) (2.6)
Income Tax Expense 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (127.8) (122.8) (130.1) (115.6) (96.8) (80.6) (76.8) (74.1) (66.9) (60.1) (57.5) (51.0) (46.0) (45.0) (41.9) (42.4) (34.6) (30.8) (27.9) (26.1) (22.9) (21.6) (18.3) (16.5) (17.4) (14.5) (14.4) (12.4) (9.0) (8.5) (7.6) (5.6) (5.5) (2.5) (2.4) (1.6) (2.6)
Per Share Data
EPS (Basic) -1.23 -1.30 -1.38 -1.23 -1.04 -0.88 -0.96 -0.94 -0.93 -0.89 -1.01 -0.94 -0.82 -0.79 -0.75 -0.79 -0.75 -0.68 -0.73 -0.70 -0.69 -0.66 -0.56 -0.53 -0.71 -0.60 -0.60 -0.51 -0.37 -0.35 -0.38 -0.25 -0.25 -0.18 -0.17 -0.12 -0.19
EPS (Diluted) -1.23 -1.30 -1.38 -1.23 -1.04 -0.88 -0.96 -0.94 -0.93 -0.89 -1.01 -0.94 -0.82 -0.79 -0.75 -0.79 -0.74 -0.68 -0.73 -0.70 -0.69 -0.66 -0.56 -0.53 -0.71 -0.60 -0.60 -0.51 -0.37 -0.35 -0.38 -0.25 -0.25 -0.18 -0.17 -0.12 -0.19
Shares Outstanding 104.1 94.1 94.2 93.8 93.1 91.5 80.1 79.0 72.3 67.1 56.8 54.3 53.9 53.8 53.8 52.5 47.4 45.2 38.3 37.1 33.0 33.0 32.9 31.4 24.5 24.2 24.2 24.2 24.1 24.0 20.0 22.0 22.0 13.9 13.9 13.9 13.9
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q1
Current Assets
Cash & Cash Equivalents 114.3 101.5 110.9 53.7 94.6 264.5 317.3 302.2 395.9 54.9 142.8 39.6 41.2 32.7 30.9 62.3 145.5 200.7 161.5 178.8 105.6 93.1 117.8 160.8 50.9 40.3 66.6 59.7 62.8 45.0 169.7 68.4 73.7 14.2 (12.2)
Short-Term Investments 1,177.0 926.4 981.4 1,142.6 1,179.6 1,089.5 545.4 560.8 505.0 503.7 411.9 225.0 254.9 301.8 337.4 346.2 174.2 133.0 31.8 25.0 45.1 77.8 69.0 44.4 61.9 78.1 65.1 85.3 94.4 118.9 0 0 0 0 24.3
Net Receivables 5.7 0.6 0 0 7.3 8.5 7.0 5.1 9.4 9.4 11.6 2.4 2.3 2.4 2.3 2.1 1.5 2.0 1.0 1.0 0.9 1.8 1.8 1.5 1.2 1.4 1.0 0.6 0.8 0 0.5 1.2 0.7 0 0
Inventory 3.1 2.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.1 0
Other Current Assets 22.4 17.8 0.5 20.9 3.2 1.7 1.5 1.5 3.6 1.6 3.5 2.8 0 2.5 1.7 1.6 1.6 0 0 0 0 1.0 0 0 0 1.1 0 0 0 0 0 0.3 0.2 0 0
Total Current Assets 1,322.4 1,048.3 1,121.3 1,217.3 1,291.1 1,375.4 877.6 874.8 917.2 574.2 575.8 284.8 305.4 345.2 378.3 416.3 328.2 344.7 204.0 211.4 157.8 177.5 194.1 210.6 117.2 123.3 135.4 147.8 159.1 166.7 171.0 69.9 74.7 15.2 12.2
Non-Current Assets
Property, Plant & Equipment 53.3 54.8 55.5 56.6 55.3 55.6 56.0 57.3 57.6 57.4 57.8 4.5 4.6 5.0 5.2 4.8 4.5 4.7 4.9 5.1 5.2 5.4 5.7 6.0 6.2 6.5 6.6 6.9 7.1 4.2 4.4 1.8 0.5 0.4 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0.8 0.8 0 0.8 0 2 1.3 2 1.3 1.8 6.0 0 0 2.0 0 0 0 1.0 0 0 0 0 0 0 0 0.5 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 24.8 22.3 19.2 14.9 14.9 1.6 2.5 1.5 2 2.0 2 4.0 4.0 0.0 1.4 0.6 0.6 0.6 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.1 0.5 0.5 0.5 0.5 1.3 3.0 1.1 0.0 (12.2)
Total Non-Current Assets 78.9 87.2 74.8 72.3 70.3 59.2 59.8 60.8 60.9 61.2 65.8 8.4 8.6 7.0 6.6 5.4 5.0 6.3 5.4 5.6 5.7 6.0 6.2 6.5 6.7 7.0 7.1 7.4 7.6 4.7 5.6 4.8 1.6 0.4 (12.2)
Total Assets 1,401.3 1,135.5 1,196.0 1,289.6 1,361.3 1,434.6 937.4 935.5 978.2 635.4 641.5 293.3 314.0 352.2 384.9 421.7 333.3 351.0 209.4 216.9 163.6 183.4 200.3 217.1 123.9 130.4 142.5 155.1 166.8 171.4 176.7 74.7 76.3 15.6 0
Current Liabilities
Account Payables 12.9 22.6 6.1 11.3 9.8 5.9 4.9 8.9 10.8 6.5 5.8 4.8 5.9 6.9 5.9 9.0 12.1 3.4 6.2 7.1 6.2 3.5 4.7 6.8 8.3 2.7 2.1 2.7 2.0 1.5 1.4 2.6 1.3 0.4 0
Short-Term Debt 6.5 6.5 0 0 0 0 0 0 5.8 4.2 4.0 0 0 1.1 0 0 0 0 0 0 0 0 0 0 0 0.7 0 0 0 0 0 0 0 0 0
Deferred Revenue 1.3 1.2 0 1.9 2.2 2.2 1.7 2.6 2.5 2.1 1.7 2.1 2.1 2.2 2.3 2.5 2.7 0 0 0 0 0 0 0 0 0 0 0 5.5 0 0 0 0 0 0
Other Current Liabilities 24.6 19.2 1.6 48.6 16.6 0.0 26.2 20.4 17.9 16.6 16.1 8.6 6.8 8.5 7.7 6.4 5.4 7.5 6.3 4.8 4.1 4.9 4.1 3.1 2.5 2.8 0 0 0 0.6 0 0 0 0 0
Total Current Liabilities 71.1 85.1 74.2 68.4 57.3 59.7 53.6 54.4 51.8 43.9 40.5 32.6 26.3 27.7 24.6 26.1 20.3 16.0 12.4 11.9 10.3 10.5 8.8 9.9 10.8 8.3 7.9 7.8 8.8 7.9 5.5 5.6 3.1 0.9 0
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 9.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 4.9 3.2 7.0 2.3 1.8 0.8 0.5 0.2 0 0 0 0 0 0 0 0 0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 3.3 3.6 94.2 93.2 29.7 0
Total Non-Current Liabilities 49.6 58.3 49.7 49.7 50.0 50.1 50.8 50.4 51.5 52.3 53.3 6.5 7.4 8.1 9.0 9.5 10.0 3.1 3.3 3.6 3.8 4.0 4.3 4.5 4.7 4.9 5.1 5.3 5.6 3.3 3.6 94.2 93.2 29.7 0
Total Liabilities 120.7 143.4 123.9 118.0 107.3 109.8 104.4 104.8 103.2 96.2 93.8 39.1 33.7 35.8 33.5 35.6 30.2 19.1 15.8 15.5 14.1 14.5 13.1 14.3 15.4 13.2 13.0 13.0 14.4 11.2 9.2 99.9 96.3 30.6 0
Stockholders' Equity
Common Stock 2,828.2 2,407.8 2,364.7 2,334.5 2,300.9 2,276.0 1,702.5 1,625.6 1,595.4 1,191.8 1,142.2 792.0 768.0 759.4 750.6 742.0 615.1 607.6 438.1 418.0 340.0 336.5 333.2 330.3 219.4 210.8 208.6 206.7 204.6 0.0 0.0 0.0 0.0 0.0 0
Retained Earnings (1,545.3) (1,417.4) (1,294.6) (1,164.5) (1,048.9) (952.1) (871.5) (794.7) (720.6) (653.7) (593.6) (536.1) (485.2) (439.2) (394.2) (352.3) (309.9) (275.3) (244.5) (216.6) (190.5) (167.6) (146.0) (127.7) (111.2) (93.8) (79.3) (64.8) (52.4) (43.4) (34.9) (27.3) (21.7) (16.3) 0
Accumulated Other Comprehensive Income (2.3) 1.8 2.1 1.6 2.0 1.0 2.0 (0.2) 0.1 1.0 (0.9) (1.7) (2.5) (3.9) (5.0) (3.6) (2.2) (0.4) (0.0) 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.2 0.1 0.1 (0.5) (0.4) (0.4) (0.3) (6.2)
Total Stockholders' Equity 1,280.6 992.1 1,072.2 1,171.5 1,254 1,324.8 833.0 830.8 874.9 539.1 547.7 254.1 280.3 316.3 351.4 386.2 303.0 331.9 193.6 201.4 149.5 168.9 187.2 202.8 108.4 117.1 129.5 142.1 152.4 160.2 167.5 (25.2) (20.0) (15.0) 11.5
Total Liabilities & Equity 1,401.3 1,135.5 1,196.0 1,289.6 1,361.3 1,434.6 937.4 935.5 978.2 635.4 641.5 293.3 314.0 352.2 384.9 421.7 333.3 351.0 209.4 216.9 163.6 183.4 200.3 217.1 123.9 130.4 142.5 155.1 166.8 171.4 176.7 74.7 76.3 15.6 11.5
Debt Metrics
Total Debt 47.9 48.5 49.1 49.9 50.8 51.7 52.5 53.3 52.5 51.7 52.2 2.6 2.8 3.1 3.3 2.6 2.8 3.1 3.3 3.6 3.8 4.0 4.2 4.4 4.6 5.6 5.7 5.9 6.1 0 0 0 0 0 0
Net Debt (66.5) (53.0) (61.8) (3.8) (43.8) (212.8) (264.7) (248.8) (343.4) (3.2) (90.6) (37.0) (38.4) (29.6) (27.6) (59.7) (142.7) (197.6) (158.2) (175.2) (101.8) (89.1) (113.6) (156.4) (46.3) (34.8) (60.8) (53.8) (56.8) (45.0) (169.7) (68.4) (73.7) (14.2) 12.2
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1
Operating Activities
Net Income (127.8) (122.8) (130.1) (115.6) (96.8) (80.6) (76.8) (74.1) (66.9) (60.1) (57.5) (51.0) (46.0) (45.0) (41.9) (42.4) (34.6) (30.8) (27.9) (26.1) (22.9) (21.6) (18.3) (16.5) (17.4) (14.5) (14.4) (12.4) (9.0) (8.5) (7.6) (5.6) (5.5) (2.5) (2.4) (1.6) (2.6)
Depreciation & Amortization 1.2 1.0 1.0 1.0 0.9 0.8 0.8 0.8 0.5 0.3 0.3 0.3 0.4 0.4 0.2 0.3 0.3 0.2 0.2 0.2 0.3 0.3 0.2 0.2 0.2 0.3 0.2 0.2 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0
Stock-Based Compensation 29.7 21.7 22.7 26.1 20.5 18.8 18.1 18.9 13.5 11.6 11.0 10.2 0 0 7.4 0 0 5.2 4.6 4.2 0 0 2.8 2.5 2.1 0 1.9 1.6 1.0 0.8 0.8 0.3 0.4 0.1 0.1 0.1 0.1
Change in Working Capital (26.2) 9.3 (1.5) 6.6 (9.5) (0.3) (0.1) 9.4 2.7 8.3 4.9 (4.4) (0.7) 2.4 (4.2) 6.8 13.7 3.3 (2.8) 1.5 (1.0) 2.4 (2.8) (2.1) 2.9 (0.8) (1.0) (1.7) 1.4 1.9 1.0 0.9 1.6 (0.1) (0.2) (0.6) 0.2
Other Non-Cash Items (1.5) (2.1) (2.8) (3.9) (3.5) (3.4) (2.8) (2.7) (2.5) 1.4 7.2 0.1 5.6 7.0 (0.0) 7.3 7.1 (1.0) 0.2 0.2 3.5 3.0 0.1 (0.1) 0.0 1.6 0.1 0.1 0.0 (0.4) 0.0 0.1 0.0 0.0 0.0 (0.1) 0.2
Operating Cash Flow (124.7) (92.9) (110.7) (85.9) (88.5) (64.7) (60.8) (47.6) (52.9) (38.5) (41.3) (45.7) (40.7) (35.2) (38.5) (28.0) (13.5) (22.9) (25.7) (19.9) (20.1) (15.9) (18.0) (15.9) (12.2) (13.4) (13.6) (12.6) (6.8) (6.0) (5.7) (4.3) (3.4) (2.5) (2.4) (2.2) (2.3)
Investing Activities
Capital Expenditure (0.8) (0.5) (0.9) (3.2) (1.2) (1.0) (0.5) (1.0) (1.3) (0.9) (3.5) (0.2) (0.0) (0.3) (0.7) (0.6) (0.1) (0.0) (0.1) (0.2) (0.1) (0.0) (0.1) (0.0) (0.1) (0.0) 0 (0.1) (0.4) (0.3) (0.3) (0.5) (0.1) (0.2) (0.0) (0.0) (0.0)
Acquisitions 0 0 0 0 0 0 0 0 0 0 189.8 (31.7) 0 0 0 0 0 101.8 0 0 0 0 0 0 (0.2) 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments (556.6) (212.0) (216.7) (182.9) (391.2) (725.0) (130.0) (192.0) (99.7) (173.1) (277.6) (59.5) (22.7) (33.6) (48.7) (192.6) (55.0) (102.0) (20.8) 0 (2.5) (21.8) (43.7) (47.2) (22.9) (41.1) (14.4) (21.1) (31.6) (118.4) 0 0 0 0 0 0 0
Sales/Maturities of Investments 302.9 271.2 382.4 224.0 306.5 184.0 151.1 139.3 101.4 86.7 87.8 91.2 71.4 70.7 56.2 18.9 11.7 0.2 14.0 20 35.2 13.0 18.9 64.8 39.3 28.3 34.9 30.6 56.6 0 0 0 0 0 0 0 0
Other Investing Activities 2.2 (1.6) 0 0 0 0 0 0 0 0 (189.8) 31.7 0 0 0 0 0 (101.8) 0 0 0 0 0 0 0.2 0 20.4 9.5 25.0 (118.4) 0 0 0 0 0 0 0
Investing Cash Flow (252.4) 57.1 164.8 38.0 (86.0) (542.1) 20.6 (53.6) 0.3 (87.3) (193.3) 31.4 48.8 36.9 6.8 (174.3) (43.4) (101.8) (7.0) 19.8 32.5 (8.9) (24.8) 17.6 16.3 (12.8) 20.4 9.4 24.6 (118.7) (0.3) (0.5) (0.1) (0.2) (0.0) (0.0) (0.0)
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.2) (0.0) (0.0) (0.0)
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.1) 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 0 0 0 9.5 23.1 (2.6) 10.4 9.2 8.9 1.3 0 0 1.1 0 0 1.8 0.5 0.7 0 0 0.1 0.1 0.1 0 0.0 0.1 0.0 0 0.7 (0.5) (63.3) 0 0.0 0 0.1
Financing Cash Flow 389.9 26.0 3.1 7.1 4.4 554.0 55.3 7.5 393.6 37.9 337.9 12.7 0.5 0.1 1.1 119.0 1.8 163.9 15.5 73.3 0.1 0.1 (0.2) 108.2 6.5 0.0 0.0 0.0 0.0 0.0 107.2 (0.5) 63.5 7.1 (0.0) 4.7 0.1
Cash Position
Net Change in Cash 12.8 (9.9) 57.2 (40.8) (170.0) (52.7) 15.1 (93.8) 341.0 (87.9) 103.2 (1.6) 8.5 1.8 (30.6) (83.3) (55.1) 39.2 (17.2) 73.2 12.5 (24.7) (43.0) 109.9 10.6 (26.3) 6.9 (3.1) 17.9 (124.7) 101.2 (5.3) 60.0 4.3 (2.5) 2.5 (2.3)
Cash at Beginning 102.3 112.2 54.2 95.1 265.0 318.6 303.5 397.2 54.9 142.8 39.6 42.5 32.7 30.9 62.8 145.5 200.7 162.0 179.3 106.1 93.1 117.8 161.3 51.4 40.8 66.6 60.2 63.3 45.5 170.2 68.9 74.2 14.2 9.9 12.3 9.9 12.2
Cash at End 115.1 102.3 111.4 54.2 95.1 265.8 318.6 303.5 395.9 54.9 142.8 40.9 41.2 32.7 32.2 62.3 145.5 201.2 162.0 179.3 105.6 93.1 118.3 161.3 51.4 40.3 67.1 60.2 63.3 45.5 170.2 68.9 74.2 14.2 9.9 12.3 9.9
Free Cash Flow (125.5) (93.4) (111.6) (89.1) (89.7) (65.7) (61.3) (48.6) (54.2) (39.5) (44.8) (46.0) (40.7) (35.5) (39.2) (28.6) (13.6) (22.9) (25.8) (20.1) (20.2) (16.0) (18.1) (15.9) (12.3) (13.5) (13.6) (12.6) (7.2) (6.3) (5.9) (4.8) (3.5) (2.7) (2.5) (2.2) (2.3)
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1
Income Statement
Revenue 10.7 6.2 0.1 1.0 0.4 0 0 0.4 0.6 0 0.3 1.0 2.7 0.7 0.5 0.4 3.1 1.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 10.5 6.2 0.1 1.0 0.4 0 0 0.4 0.6 0 0.3 1.0 2.7 0.7 0.5 0.4 3.1 1.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Income (140.4) (133.7) (142.6) (129.1) (111.4) (94.7) (87.8) (82.8) (73.5) (62.7) (59.0) (53.0) (48.0) (47.6) (43.5) (43.0) (33.8) (30.9) (27.8) (26.1) (22.9) (21.8) (18.5) (16.9) (17.8) (15.2) (15.2) (13.3) (10.0) (9.4) (8.1) (5.7) (5.5) (2.5) (2.4) (1.6) (2.6)
Net Income (127.8) (122.8) (130.1) (115.6) (96.8) (80.6) (76.8) (74.1) (66.9) (60.1) (57.5) (51.0) (46.0) (45.0) (41.9) (42.4) (34.6) (30.8) (27.9) (26.1) (22.9) (21.6) (18.3) (16.5) (17.4) (14.5) (14.4) (12.4) (9.0) (8.5) (7.6) (5.6) (5.5) (2.5) (2.4) (1.6) (2.6)
EPS (Diluted) -1.23 -1.30 -1.38 -1.23 -1.04 -0.88 -0.96 -0.94 -0.93 -0.89 -1.01 -0.94 -0.82 -0.79 -0.75 -0.79 -0.74 -0.68 -0.73 -0.70 -0.69 -0.66 -0.56 -0.53 -0.71 -0.60 -0.60 -0.51 -0.37 -0.35 -0.38 -0.25 -0.25 -0.18 -0.17 -0.12 -0.19
Balance Sheet
Cash & Equivalents 114.3 101.5 110.9 53.7 94.6 264.5 317.3 302.2 395.9 54.9 142.8 39.6 41.2 32.7 30.9 62.3 145.5 200.7 161.5 178.8 105.6 93.1 117.8 160.8 50.9 40.3 66.6 59.7 62.8 45.0 169.7 68.4 73.7 14.2 (12.2)
Total Assets 1,401.3 1,135.5 1,196.0 1,289.6 1,361.3 1,434.6 937.4 935.5 978.2 635.4 641.5 293.3 314.0 352.2 384.9 421.7 333.3 351.0 209.4 216.9 163.6 183.4 200.3 217.1 123.9 130.4 142.5 155.1 166.8 171.4 176.7 74.7 76.3 15.6 0
Total Debt 47.9 48.5 49.1 49.9 50.8 51.7 52.5 53.3 52.5 51.7 52.2 2.6 2.8 3.1 3.3 2.6 2.8 3.1 3.3 3.6 3.8 4.0 4.2 4.4 4.6 5.6 5.7 5.9 6.1 0 0 0 0 0 0
Stockholders' Equity 1,280.6 992.1 1,072.2 1,171.5 1,254 1,324.8 833.0 830.8 874.9 539.1 547.7 254.1 280.3 316.3 351.4 386.2 303.0 331.9 193.6 201.4 149.5 168.9 187.2 202.8 108.4 117.1 129.5 142.1 152.4 160.2 167.5 (25.2) (20.0) (15.0) 11.5
Cash Flow
Operating Cash Flow (124.7) (92.9) (110.7) (85.9) (88.5) (64.7) (60.8) (47.6) (52.9) (38.5) (41.3) (45.7) (40.7) (35.2) (38.5) (28.0) (13.5) (22.9) (25.7) (19.9) (20.1) (15.9) (18.0) (15.9) (12.2) (13.4) (13.6) (12.6) (6.8) (6.0) (5.7) (4.3) (3.4) (2.5) (2.4) (2.2) (2.3)
Capital Expenditure (0.8) (0.5) (0.9) (3.2) (1.2) (1.0) (0.5) (1.0) (1.3) (0.9) (3.5) (0.2) (0.0) (0.3) (0.7) (0.6) (0.1) (0.0) (0.1) (0.2) (0.1) (0.0) (0.1) (0.0) (0.1) (0.0) 0 (0.1) (0.4) (0.3) (0.3) (0.5) (0.1) (0.2) (0.0) (0.0) (0.0)
Free Cash Flow (125.5) (93.4) (111.6) (89.1) (89.7) (65.7) (61.3) (48.6) (54.2) (39.5) (44.8) (46.0) (40.7) (35.5) (39.2) (28.6) (13.6) (22.9) (25.8) (20.1) (20.2) (16.0) (18.1) (15.9) (12.3) (13.5) (13.6) (12.6) (7.2) (6.3) (5.9) (4.8) (3.5) (2.7) (2.5) (2.2) (2.3)